Peptide record

TPDB11945

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Blood-Brain Barrier Toxicity standard
41 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11945
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Blood-Brain Barrier Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb dbAMP 3.0 i2APP AI4AVP AVPpred-BWR DRAVP 2.0 BBPpredict
standard
No
A 41-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C188H311N55O50S6
NEMW
CG
4334.24
9.24
8
1
10
+6
0.90
-0.102
64.15
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1865
0.43
12
Residue Composition
number
1
A
2
R
0
N
1
D
6
C
0
E
1
Q
6
G
1
H
3
I
2
L
5
K
0
M
1
F
5
P
1
S
3
T
0
W
1
Y
2
V
Amino Acid Distribution
A: 1 R: 2 N: 0 D: 1 C: 6 E: 0 Q: 1 G: 6 H: 1 I: 3 L: 2 K: 5 M: 0 F: 1 P: 5 S: 1 T: 3 W: 0 Y: 1 V: 2
Chemical Descriptors
41 reviewed residue count
C188H311N55O50S6 sequence-only estimate (linear, free termini)
4334.24 sequence-only estimate (linear, free termini)
9.24 sequence-only estimate (linear, free termini)
+6 sequence-only estimate (linear, free termini)
0.90 sequence-only estimate (linear, free termini)
-0.102 sequence-only estimate (linear, free termini)
Evidence Records 4 records
Evidence 1 Activity

Activity

0% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins. | Biopolymers | 2005
Evidence 2 Activity

Activity

3% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
3% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins. | Biopolymers | 2005
Evidence 3 Activity

Activity

11% Hemolysis
Toxicity
500 µg/mL
Hemolytic Cytotoxic
11% Hemolysis | 500 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins. | Biopolymers | 2005
Evidence 4 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.15625724] It is slightly hemolytic (<12%) against human erythrocytes at the highest concentration of 500 µg/ml.

Target

erythrocytes

Source & Reference

NA
DRAMP
Nature. 1997 Jun 26 387(6636):861.##J Biol Chem. 2000 Oct 20 275(42):32911-32918.##Plant Cell Rep. 2007 Aug 26(8):1391-1398.